Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.03224-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Isabelle Bonnet und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cimi-Paris, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Bacterial Proteins, Tuberculosis, Multidrug-Resistant, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Infrastructures en Biologie Santé et Agronomie.
Abstract (Originalsprache)
Multidrug-resistant (MDR) strains of Mycobacterium tuberculosis represent an obstacle to eradicating tuberculosis (TB) due to the low treatment success rate of MDR TB. Among them, the MDR B0/W148 clone has recently evolved from the M. tuberculosis Beijing lineage 2 and is widely disseminated in Russia and Europe. To get more insights into the genetic factors underlying the evolutionary success of the MDR M. tuberculosis B0/W148 clone in addition to environmental and patient-related features, we focused on two mutations specific to this clone that are found in the transcriptional regulators WhiB6 and KdpDE and investigated in a H37Rv strain background the transcriptional profile associated with these mutations and their impact on the in vitro and in vivo growth characteristics. Through the construction and use of H37Rv∆ whiB6 , H37Rv∆ kdpDE , and complemented strains, neither mutation impaired the in vitro growth of M. tuberculosis in standard mycobacterial growth media. The mutation T51P in whiB6 prevented the upregulation of 9 genes in the esx-1 core region and 44 genes elsewhere in the genome, while the deletion of two nucleotides in kdpD leads to a fusion protein of KdpD with KdpE that inhibits the transcriptional activity of KdpE. Neither mutation led to hypervirulence in a mouse infection model. These results point to the role of other MDR B0/W148 specific mutations in the wide geographic diffusion of this clone and/or put in question a hypothesized hypervirulence as a driving factor for this large dissemination. IMPORTANCE Human tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis , remains a global public health issue estimated to have been responsible for 1.25 million deaths in 2023. Multidrug-resistant (MDR) strains of M. tuberculosis , resistant to rifampicin and isoniazid, lead to lower treatment success. Among them, the MDR B0/W148 clone has widely disseminated in Russia and Europe. To get more insights into the genetic factors underlying the evolutionary success of this clone, we investigated two strain-specific mutations found in the transcriptional regulators WhiB6 and KdpDE. By constructing and analyzing laboratory M. tuberculosis strains carrying these specific mutations, we found numerous changes in their transcriptional profiles, whereas we observed only a little impact of these mutations on the virulence of M. tuberculosis in a mouse infection model. Our study provides new insights into the transcriptional landscape of the selected MDR strains, although no direct connection to virulence could be established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cimi-Paris, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Paris, France.
- Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne-Université, Paris, France.
- Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Unit for Integrated Mycobacterial Pathogenomics, Paris, France.
- Institut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France.
- Institut Pasteur, Université Paris Cité, Photonic Bio-Imaging, Centre de Ressources et Recherches Technologiques (UTechS-PBI, C2RT), Paris, France.
ORCID-Profile: Isabelle Bonnet, Hugo Varet, Roland Brosch, Régis Tournebize
Förderung
- Agence Nationale de la Recherche
- Infrastructures en Biologie Santé et Agronomie
Zitieren
APA
Bonnet, I., Orgeur, M., Brossier, F., Sayes, F., Frigui, W., Madacki, J., Varet, H., Chauffour, A., Aubry, A., Veziris, N., Sougakoff, W., Brosch, R., & Tournebize, R. (2025). Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03224-24
Vancouver
Bonnet I, Orgeur M, Brossier F, Sayes F, Frigui W, Madacki J, et al. Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148. Microbiology Spectrum. 2025. doi:10.1128/spectrum.03224-24
BibTeX
@article{Bonnet2025,
author = {Bonnet, Isabelle and Orgeur, Mickael and Brossier, Florence and Sayes, Fadel and Frigui, Wafa and Madacki, Jan and Varet, Hugo and Chauffour, Aurélie and Aubry, Alexandra and Veziris, Nicolas and Sougakoff, Wladimir and Brosch, Roland and Tournebize, Régis},
title = {Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.03224-24}
}
EUVIMED